Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Human loss-of-function variants suggest that partial LRRK... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinsons disease
0
Authors
Nicola Whiffin
•
Irina Armean
37 more
•
Daniel MacArthur
Published
September 18, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Bioinformatics
Internal Medicine
Genomics
Neurology
Genetics And Genomics
Biology
Bioinformatics
Medicine
Internal Medicine
Genomics
Show all topics
DOI
10.1101/561472
License
CC-BY
Other Formats
PDF
